Procter & Gamble Hygiene recommends ₹60 dividend; FY26 results show revenue at ₹4,290 crore

CONSUMER-PRODUCTS
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Procter & Gamble Hygiene recommends ₹60 dividend; FY26 results show revenue at ₹4,290 crore
Overview

Procter & Gamble Hygiene and Health Care Ltd. announced audited financial results for the year ended March 31, 2026. The company recommended a final dividend of ₹60 per equity share and reported revenue from operations at ₹4,290.42 crore. Auditors issued an unmodified opinion.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Procter & Gamble Hygiene Announces FY26 Results and ₹60 Dividend

Revenue from operations for the 12 months ended March 31, 2026, stood at ₹4,290.42 crore.
Profit for the period was ₹856.50 crore.

Reader Takeaway: Strong revenue and profit figures; dividend boost signals confidence despite accounting period changes.

What just happened

Procter & Gamble Hygiene and Health Care Limited has released its audited financial results for the fiscal year ended March 31, 2026. The company reported revenue from operations of ₹4,290.42 crore and profit for the period of ₹856.50 crore. A key announcement is the Board's recommendation of a final dividend of ₹60 per equity share, subject to shareholder approval.

Why this matters

For shareholders, the recommended dividend offers a direct return on investment. The reported financial performance, particularly revenue and profit, provides insight into the company's operational health. However, investors must be aware that direct year-on-year comparisons are challenging due to the shift to a March 31st financial year-end, with the previous year reported for nine months.

The backstory

The company has transitioned its financial year-end to March 31st. The previous reporting period covered nine months (ending March 31, 2025), while the current period covers a full twelve months (ending March 31, 2026). This change in reporting structure means that simple percentage growth calculations between these two periods are not directly applicable.

What changes now

With the financial year-end aligned to March 31st, future financial reports will provide more straightforward annual comparisons. The recommended dividend of ₹60 per share, if approved, will be paid out by September 18, 2026, providing a tangible benefit to shareholders.

Risks to watch

The primary challenge for investors is the difficulty in performing direct year-on-year growth analysis due to the difference in reporting periods (12 months vs. 9 months). Any investment decisions should account for this anomaly in the presented financial data.

Peer comparison

While specific peer comparisons are not detailed in this filing, the dividend payout and reported financials will be viewed against industry benchmarks. Companies in the Fast-Moving Consumer Goods (FMCG) sector, where P&G Hygiene operates, often focus on consistent revenue growth and shareholder returns through dividends and buybacks.

Context metrics

For the 12 months ended March 31, 2026:

  • Revenue from operations: ₹4,290.42 crore
  • Profit before tax: ₹1,166.63 crore
  • Profit for the period: ₹856.50 crore
  • Basic Earnings per Share: ₹263.86

What to track next

Investors should track the outcome of the 62nd Annual General Meeting regarding the dividend approval. Future quarterly and annual results will be crucial for understanding the company's performance on a consistent, comparable annual basis.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.